XML 47 R5.htm IDEA: XBRL DOCUMENT v2.4.1.9
Statements of Cash Flows (USD $)
 9 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Cash flows from operating activities:    
Net loss $ (5,567,960)us-gaap_NetIncomeLoss $ (3,852,119)us-gaap_NetIncomeLoss
Stock-based compensation expense 749,810us-gaap_ShareBasedCompensation 385,342us-gaap_ShareBasedCompensation
Depreciation and amortization 73,746us-gaap_DepreciationDepletionAndAmortization 63,596us-gaap_DepreciationDepletionAndAmortization
Amortization of prepaid research and development-related party (Note 9) 91,488rswn_AmortizationOfPrepaidResearchAndDevelopmentDueToRelatedParties 5,083rswn_AmortizationOfPrepaidResearchAndDevelopmentDueToRelatedParties
Deferred taxes (23,910)us-gaap_DeferredIncomeTaxExpenseBenefit (549,159)us-gaap_DeferredIncomeTaxExpenseBenefit
Adjustments to reconcile net loss to net cash used in operating activities:    
(Increase) decrease in accounts receivable (1,036)us-gaap_IncreaseDecreaseInAccountsReceivable 24,000us-gaap_IncreaseDecreaseInAccountsReceivable
(Increase) in inventory (11,233)us-gaap_IncreaseDecreaseInInventories  
Decrease (increase) in prepaid expenses 496,322us-gaap_IncreaseDecreaseInPrepaidExpense (348,510)us-gaap_IncreaseDecreaseInPrepaidExpense
(Increase) in prepaid research and development-related party (Note 9) (150,000)rswn_IncreaseDecreaseInPrepaidResearchAndDevelopmentDueToRelatedParties (315,000)rswn_IncreaseDecreaseInPrepaidResearchAndDevelopmentDueToRelatedParties
(Decrease) increase in accounts payable (103,158)us-gaap_IncreaseDecreaseInAccountsPayable 582,899us-gaap_IncreaseDecreaseInAccountsPayable
(Decrease) increase in related party payable (392,509)us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties 299,469us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties
(Decrease) in deferred revenue (64,286)us-gaap_IncreaseDecreaseInDeferredRevenue (37,500)us-gaap_IncreaseDecreaseInDeferredRevenue
Increase in accrued compensation 98,949rswn_IncreaseDecreaseInAccruedCompensation  
(Decrease) increase in accrued interest payable (42,673)us-gaap_IncreaseDecreaseInInterestPayableNet 12,033us-gaap_IncreaseDecreaseInInterestPayableNet
Net cash used in operating activities (4,846,450)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations (3,729,866)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash flows used in investing activities:    
Deposits (1,998)us-gaap_PaymentsForDeposits  
Net cash used in investing activities (1,998)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations  
Cash flows from financing activities:    
Proceeds from convertible note to Ampio 3,700,000us-gaap_ProceedsFromConvertibleDebt 4,300,000us-gaap_ProceedsFromConvertibleDebt
Contribution of Ampio   637,209us-gaap_ProceedsFromContributedCapital
Net cash provided by financing activities 3,700,000us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations 4,937,209us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
Net change in cash and cash equivalents (1,148,448)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease 1,207,343us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Cash and cash equivalents at beginning of period 2,639,650us-gaap_CashAndCashEquivalentsAtCarryingValue 2,913,701us-gaap_CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents at end of period 1,491,202us-gaap_CashAndCashEquivalentsAtCarryingValue 4,121,044us-gaap_CashAndCashEquivalentsAtCarryingValue
Non-cash transactions:    
Issuance of common stock in exchange for Vyrix acquired assets   6,803,356rswn_IssuanceOfCommonStockInExchangeForAcquiredAssets
Related party-prepaid research and development and accrued liability not paid at March 31, 2014   $ 300,000rswn_PrepaidResearchAndDevelopmentAndAccruedLiabilityRelatedPartiesUnpaid